MACKAY SHIELDS LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,357,000
-45.3%
99,100
-39.8%
0.02%
-43.3%
Q4 2020$4,306,000
+31.7%
164,600
-12.4%
0.03%
+36.4%
Q3 2020$3,269,000
-8.0%
187,800
-11.1%
0.02%
-21.4%
Q2 2020$3,554,000
+26.2%
211,300
-10.8%
0.03%
+7.7%
Q1 2020$2,817,000
-8.1%
236,900
-6.4%
0.03%
+23.8%
Q4 2019$3,064,000
+277.8%
253,200
+413.6%
0.02%
+320.0%
Q1 2018$811,00049,3000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders